Finance News – Executive Powers
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Investors
Shares
Tariffs
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Etf
Stablecoin
Investment
Bse
Blockchain
Ipo
Eth
Sec
Index
Solana
Trade
Inflation
Earnings
Interest Rates
Coinbase
Token
Sensex
Revenue
Wall Street
Nasdaq
China
Federal Reserve
Nse
Treasury
Traders
Bse Sensex
Sp 500
Gold
Nifty
Tesla
Economy
Investor
Usd
Profit
Pne
Financial Times
Uk Taxpayers
Us Attorney
Auastrac
Rea
Electric Air Taxi
Groq
Affluent
Mid Cap Majors
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
The Guardian – Business • May 29, 2025
The Guardian view on Trump’s tariffs: the courts have drawn a line. So must Congress | Editorial
The tariffs imposed under claims of national security have had significant economic impacts, bypassing legislative approval and contributing to market volatility while raising conc...
Read Full Article →
The Guardian – Business • May 12, 2025
Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%’
The announcement of aggressive measures to lower medication costs in the United States has caused a notable decline in the market value of companies producing pharmaceuticals.
Read Full Article →